As of 2024-12-11, the EV/EBITDA ratio of Adapthealth Corp (AHCO) is -44.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AHCO's latest enterprise value is 3,274.60 mil USD. AHCO's TTM EBITDA according to its financial statements is -72.83 mil USD. Dividing these 2 quantities gives us the above AHCO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.6x - 6.4x | 4.2x |
| Forward P/E multiples | 8.5x - 11.9x | 10.2x |
| Fair Price | (19.25) - (18.08) | (18.55) |
| Upside | -298.2% - -286.2% | -291.1% |
| Date | EV/EBITDA |
| 2024-12-11 | -44.96 |
| 2024-12-10 | -44.65 |
| 2024-12-09 | -44.52 |
| 2024-12-06 | -45.00 |
| 2024-12-05 | -44.98 |
| 2024-12-04 | -44.93 |
| 2024-12-03 | -44.72 |
| 2024-12-02 | -45.57 |
| 2024-11-29 | -45.55 |
| 2024-11-27 | -45.48 |
| 2024-11-26 | -45.41 |
| 2024-11-25 | -45.72 |
| 2024-11-22 | -45.23 |
| 2024-11-21 | -45.30 |
| 2024-11-20 | -44.98 |
| 2024-11-19 | -45.02 |
| 2024-11-18 | -44.70 |
| 2024-11-15 | -44.83 |
| 2024-11-14 | -45.57 |
| 2024-11-13 | -46.61 |
| 2024-11-12 | -46.77 |
| 2024-11-11 | -46.33 |
| 2024-11-08 | -45.66 |
| 2024-11-07 | -45.18 |
| 2024-11-06 | -45.83 |
| 2024-11-05 | -43.98 |
| 2024-11-04 | -45.78 |
| 2024-11-01 | -46.42 |
| 2024-10-31 | -46.03 |
| 2024-10-30 | -46.92 |
| 2024-10-29 | -47.07 |
| 2024-10-28 | -47.01 |
| 2024-10-25 | -46.70 |
| 2024-10-24 | -46.53 |
| 2024-10-23 | -46.66 |
| 2024-10-22 | -47.25 |
| 2024-10-21 | -47.07 |
| 2024-10-18 | -47.35 |
| 2024-10-17 | -47.03 |
| 2024-10-16 | -47.09 |
| 2024-10-15 | -46.57 |
| 2024-10-14 | -45.54 |
| 2024-10-11 | -45.66 |
| 2024-10-10 | -45.46 |
| 2024-10-09 | -45.96 |
| 2024-10-08 | -45.98 |
| 2024-10-07 | -45.83 |
| 2024-10-04 | -46.31 |
| 2024-10-03 | -46.26 |
| 2024-10-02 | -47.01 |